Acquired hypopigmentation (leukoderma) as a presenting feature of metastatic amelanotic melanoma with brain involvement.
Karakis
Ioannis
I
Department of Neurology, Boston University Medical Center, Boston, MA 02118, USA. ioannis.karakis@bmc.org
McGeeney
Brian
B
Demierre
Maria-France
MF
Thiele
Jens J
JJ
Wolpowitz
Deon
D
Bhawan
Jag
J
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D001921:Brain / Q000473:pathology; D001932:Brain Neoplasms / Q000473:pathology / Q000532:radiotherapy / Q000556:secondary*; D003606:Dacarbazine / Q000031:analogs & derivatives / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D006801:Humans; D017496:Hypopigmentation / Q000209:etiology* / Q000473:pathology; D007124:Immunoenzyme Techniques; D008279:Magnetic Resonance Imaging; D008297:Male; D018328:Melanoma, Amelanotic / Q000473:pathology*; D008875:Middle Aged; D009460:Neurologic Examination; D012878:Skin Neoplasms / Q000473:pathology*; D000077204:Temozolomide
D000893:Anti-Inflammatory Agents; D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine; D003907:Dexamethasone; D000077204:Temozolomide